Weight loss in your first week on Mounjaro: what to expect

The first injection: what your body is doing while the scales stay still

You've done your consultation, your pen has arrived, and you've taken your first dose. Then you step on the scales two days later and see almost nothing has changed. This is the moment many people worry they've made a mistake — and it's a worry worth letting go of gently, because it's based on a misreading of how tirzepatide works.

Mounjaro activates two gut-hormone receptors, GIP and GLP-1, which together slow how quickly your stomach empties and help regulate appetite signals in the brain. That process begins with the first dose. What it doesn't do is immediately mobilise stored fat in a way you'd see on the scales. In the opening days, your body is adjusting to a new hormonal environment. You may notice you feel full sooner at meals, or that the urge to snack has quietened. That shift in appetite is the mechanism starting to work, the weight loss follows it, not the other way around.

The timeline for Mounjaro to take effect is measured in weeks rather than days, and that's consistent with how the medicine was studied. In SURMOUNT-1, the landmark trial published in the New England Journal of Medicine, participants lost weight progressively across 72 weeks, with the curve steepening as doses increased over time. A first week is a tiny slice of that picture.

Why the number on the scales can mislead you early on

Even when something does shift in week one, it rarely means what people assume. Starting a new medicine, changing your eating habits, drinking differently, or sleeping less can all move the scales by a kilogram or two in either direction within days. That movement is almost entirely water and glycogen fluctuation, not fat tissue.

Fat loss requires a sustained calorie deficit over time. Mounjaro helps create that deficit by reducing appetite, but the deficit needs to accumulate before body-fat changes become measurable. This is why clinicians talk about what the first month on Mounjaro looks like rather than the first week: a month gives you enough signal to see a genuine trend. Most people who stay on treatment begin to notice clothing fitting differently or a clearer downward drift on the scales somewhere between weeks two and five on the starting dose, though this varies.

It's also worth knowing that tirzepatide's starter dose is deliberately cautious. The 2.5mg level was designed to reduce the chance of nausea and other gastrointestinal side effects as your body adapts. The doses associated with the strongest results in trials (10mg and 15mg) are reached gradually over months, under prescriber guidance. Early weeks are foundational, not definitive.

What a realistic first week looks like, and when to pay attention

A typical first week might include: meals that feel satisfying with less food than usual, perhaps some mild nausea or an unsettled stomach for a day or two after the injection, and scale readings that are broadly similar to your starting weight. Some people do see a small early drop; others see a slight uptick before a downward trend begins. Both experiences are reported.

What the first week is not a good basis for is comparison. Whether you lost 0.5kg or nothing at all, it tells you very little about where you'll be after three months on treatment. If you're curious about how quickly weight loss typically progresses on Mounjaro, the honest answer is that pace is individual and dose-dependent. The SURMOUNT-1 data showed average reductions of around 20–21% of body weight at 15mg over 72 weeks among thousands of participants, a figure accumulated over the full course of treatment, not front-loaded into the opening days.

Side effects in week one are worth monitoring calmly. Nausea, loose stools or some fatigue are common and usually settle within a few days. If you experience severe or persistent stomach pain, particularly pain that travels towards your back, seek medical attention promptly and contact your prescriber. You can also report any suspected side effects via the MHRA's Yellow Card scheme. The NHS has practical guidance on what to expect from tirzepatide, including how to manage early symptoms.

When week one genuinely is cause for concern

There's a difference between a quiet first week and a first week where something feels wrong. If you're struggling with persistent vomiting, can't keep fluids down, or are experiencing side effects that feel severe rather than mild and passing, contact your prescriber rather than waiting. At nume, our prescribers are available seven days a week for aftercare, not just at the point of dispensing.

If after several weeks at the starter dose you're seeing no appetite change at all, that's a useful conversation for your next review. Our page on why some people don't lose weight in their first week on Mounjaro covers the common reasons in more detail. And if you've never started treatment yet and are weighing up how it all works, reading about Mounjaro as a treatment from the beginning is a sensible starting point. For a broader look at your options, the weight-loss treatment overview lays out what's licensed in the UK.

Starting treatment is a clinical decision made with a prescriber who has reviewed your full picture. If you'd like that conversation, check your eligibility with our team.